NSCLCICI-related pneumonitisIRPNorthwestern Universityanti-programmed cell death ligand-1(PD-L1) therapy
…nalyzing tumor and surrounding lung on baseline CT can identify NSCLC patients at elevated IRP risk. The model’s high NPV (92.9%) rel…
189articles mentioning diseases
777disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Active filtersEntity: NSCLC ×
NSCLC
This disease is selected. Its supporting articles are shown below.
Articles mentioning NSCLC
189 articles · page 6 of 16non-small cell lung cancerNSCLCdurvalumabdurvalumab-relatedchemoradiationcarboplatin
…Background One-third of patients with non-small cell lung cancer (NSCLC) are diagnosed with stage III, locally advanced disease.…
NSCLCipilimumabpembrolizumabnivolumabNorthwestern Universityimmunotherapy
…Methods A total of 101 eligible patients with stage IIIB and IV NSCLC who have been treated with ICIs were analyzed in this study. DC…
NSCLCnon-small cell lung cancernon-small cell lung carcinoma
…xture.9–11 Methods CD8 immunohistochemistry was performed on 35 NSCLC whole-slide resection specimens and a corresponding TMA compris…
Lung cancerNSCLCimmunotherapy
…Background Lung cancer accounts for 12% of all cancers and 20% of cancer-related death…
NSCLCsolid tumorsUniversity of Pittsburghimmunotherapy
…logical assessment of TLS. We used independent patient cohorts (NSCLC, ovarian, and brain metastases) to validate our findings in mul…
NSCLCnon-small cell lung cancerHNSCCmelanomahead and neck squamous cell carcinomaDPV-001Thermofisher Scientificdetergent
…assessment characterizing the immunopeptidome of 10 HNSCC and 3 NSCLC cell lines derived from 9 different patients, revealed 74,578 u…
osteosarcomanon-small cell lung cancerNSCLCsolid tumorsOSEP10EphA2
…is frequently overexpressed in multiple malignancies, including osteosarcoma (OS) and non-small cell lung cancer (NSCLC), where it is associ…
NSCLCnon-small cell lung cancerDocetaxelatezolizumabhSTC810
…articularly for patients with PD-L1-refractory or immune-desert NSCLC.…
93.5%
NSCLCmetastatic melanomaStage IV non-small cell lung cancerStage IV melanomaSARS-COV-2 mRNA vaccinesMD Anderson Cancer Center
…ociated with a near doubling of OS among patients with Stage IV NSCLC (555 days vs 1120 days, adj HR 0.5, 95% CI 0.4-0.7) and Stage I…
NSCLCAteganosinecemiplimabTHIONCT05208944ChemotherapyDocetaxel
…Docetaxel. Eligible patients must have histologically confirmed NSCLC and documented progression following prior treatment with at le…
MelanomaNSCLCImneskibartAvelumab
…or regressions and a low incidence of Grade 3/4 adverse events. Melanoma patients with primary resistance to prior doublet immune checkp…